Pizzuti Dana bought CRNX
March 4, 2024 · Form 4 insider transaction
Pizzuti Dana bought 23,000 shares of Crinetics Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,000
Price
$0.00
Total value
N/A
InsiderPizzuti Dana
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 4, 2024
Filing dateMarch 6, 2024
Shares owned after28,911
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2025.